Speculation swirls around the U.S. Department of Health and Human Services (HHS) recommendations to the U.S. Drug Enforcement Administration (DEA) on cannabis rescheduling. HHS is believed to have advised DEA to move cannabis from Schedule I to Schedule III.
The Jacobsen – Fastmarkets previously reported on President Biden’s directive to HHS to evaluate current cannabis scheduling and make recommendations. The move to Schedule III would have a dramatic impact on cannabis markets. For example, cannabis businesses would be able to take standard tax deductions that they currently cannot use.
…
11.21.2024
Domestic US biodiesel blending helps lift October RFS RIN production
US domestic biodiesel blending of 147.5 million gallons in October produced a monthly high of 221.2 million renewable identification number (RIN) credits for January-October. This was 11.5% above September...
11.21.2024
CWG trades lower as broader animal fats markets hold steady
The US animal fats and oils markets held steady on Thursday November 21, with limited trading as attention shifted toward broader macroeconomic factors and...
11.21.2024
October commercial cattle, hog production above 2023
US animal protein prices were steady on Thursday November 21. Limited trade was reported from market sources due to the proximity of the extended Thanksgiving holiday weekend in the...